Abstract: A semiconductor device capable of improving a device performance and a reliability is provided. The semiconductor device comprising a gate structure including a gate electrode on a substrate, a source/drain pattern on a side face of the gate electrode, on the substrate and, a source/drain contact connected to the source/drain pattern, on the source/drain pattern, a gate contact connected to the gate electrode, on the gate electrode, and a wiring structure connected to the source/drain contact and the gate contact, on the source/drain contact and the gate contact, wherein the wiring structure includes a first via plug, a second via plug, and a wiring line connected to the first via plug and the second via plug, the first via plug has a single conductive film structure, and the second via plug includes a lower via filling film, and an upper via filling film on the lower via filling film.

Abstract: The present disclosure relates to a method for producing stable phase crystals using physical grinding, and specifically, to a method for efficiently and stably phase-transforming a metastable phase crystal into a stable phase crystal without using chemicals such as additives for promoting the phase transformation from the metastable phase crystal into the stable phase crystal.

Abstract: The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.

Abstract: The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yppyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.

Abstract: The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yppyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.

Abstract: The present invention relates to a process of edging a lens comprising forming a lens-protective transparent coating layer on the surface of the lens. When the lens coated with a transparent coating layer comprising a fluorine-containing elastomer and optionally a fluorine-containing organosilane compound and having a surface energy of less than 15 mJ/m2 is edged, the scratch of lens during handling, the damage of lens caused by chemical contaminants, and lens off-centring phenomena can be prevented. Further, such an edging process requires no adhesive tape, making the process simple, and prevents the contamination of the lens surface. Further, the inventive transparent coating layer makes it possible to measure the diopter of lens exactly owing to its transparency and it is manually removable without a chemical.

Abstract: The present invention relates to a process of edging a lens comprising forming a lens-protective transparent coating layer on the surface of the lens. When the lens coated with a transparent coating layer comprising a fluorine-containing elastomer and optionally a fluorine-containing organosilane compound and having a surface energy of less than 15 mJ/m2 is edged, the scratch of lens during handling, the damage of lens caused by chemical contaminants, and lens off-centring phenomena can be prevented. Further, such an edging process requires no adhesive tape, making the process simple, and prevents the contamination of the lens surface. Further, the inventive transparent coating layer makes it possible to measure the diopter of lens exactly owing to its transparency and it is manually removable without a chemical.